Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.87 -0.07 (-3.61%)
As of: Oct 21, 2026 · 10:06 AM EDT

Xtl Biopharmaceuticals (XTLB) EV to EBIT (2014)

Updated

Xtl Biopharmaceuticals' (XTLB) EV to EBIT stood at 1186.61 in the quarter ended Jun 30, 2014.

Analysis

Xtl Biopharmaceuticals (XTLB) EV to EBIT (2014) Analysis & Trends

On a TTM basis, Xtl Biopharmaceuticals' EV to EBIT came in at 1167.46 as of Jun 30, 2014.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.97 Bn 1,099.55 Bn 19.71 Bn
2 Johnson & Johnson 614.97 Bn 533.50 Bn 17.26 Bn
3 AbbVie 505.56 Bn 478.67 Bn 12.70 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn
5 Novartis Ag 297.80 Bn 261.79 Bn 11.24 Bn
6 Astrazeneca 261.62 Bn 235.31 Bn 12.86 Bn
7 Amgen 235.78 Bn 191.18 Bn 7.24 Bn
8 Gilead Sciences 189.91 Bn 164.11 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Xtl Biopharmaceuticals 16.76 Mn 13.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 6.49
API Access

Xtl Biopharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=XTLB&period=max&api_key=YOUR_API_KEY